Yingying Du

Sintilimab Plus Platinum and Gemcitabine as First-Line Treatment for Advanced or Metastatic Squamous NSCLC: Results From a Randomized, Double-Blind, Phase 3 Trial (ORIENT-12)

Caicun Zhou, Caicun Zhou, Lin Wu et al. · Journal of Thoracic Oncology · 2021 · 317 citations · Full text

Medicine, Oncology, Pharmacology +8

The cell growth suppressor, mir-126, targets IRS-1

Jin Zhang, Yingying Du, Yifeng Lin et al. · Biochemical and Biophysical Research Communications · 2008 · 233 citations

Life Sciences, Cell Biology, Molecular Biology +11

Phase III KEYNOTE-789 Study of Pemetrexed and Platinum With or Without Pembrolizumab for Tyrosine Kinase Inhibitor‒Resistant, <i>EGFR</i> –Mutant, Metastatic Nonsquamous Non–Small Cell Lung Cancer

James Chih‐Hsin Yang, Dae Ho Lee, Jong‐Seok Lee et al. · Journal of Clinical Oncology · 2024 · 142 citations · Full text

Medicine, Oncology, Pharmacology +14

Emergence and Adaptation of a Novel Highly Pathogenic H7N9 Influenza Virus in Birds and Humans from a 2013 Human-Infecting Low-Pathogenic Ancestor

Wenbao Qi, Weixin Jia, Di Liu et al. · Journal of Virology · 2017 · 121 citations · Full text

Agriculture, Infectious Diseases, Poultry Science +15

miRNA-135a promotes breast cancer cell migration and invasion by targeting HOXA10

Yating Chen, Jin Zhang, Huijun Wang et al. · BMC Cancer · 2012 · 112 citations · Full text

Medicine, Cancer Biology, Oncology +16